Lifeline Business Profile
Scientists from the University Hospital of Munich have managed to grow the beginnings of a human heart valve using the stem cells from cord blood.
Scientists from the University Hospital of Munich have managed to grow the beginnings of a human heart valve using the stem cells from cord blood.
The facility of CBB Lifeline Biotech is Accredited by AABB International Standards for Cellular Therapy Products for Cord Blood Banking Services
Since October 2020 the clinical testing is performed by a third party accredited collaborator
LifeCord Patented Methodology
US Patent Office
